Fulgent Genetics, Inc. FLGT Increase (decrease) in contract liabilities and current deferred income
Increase (decrease) in contract liabilities and current deferred income at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s increase (decrease) in contract liabilities and current deferred income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s increase (decrease) in contract liabilities and current deferred income?
- Fulgent Genetics, Inc. (FLGT) reported increase (decrease) in contract liabilities and current deferred income of -$627K in Q1 2026.
- How has Fulgent Genetics, Inc.'s increase (decrease) in contract liabilities and current deferred income changed year-over-year?
- Fulgent Genetics, Inc.'s increase (decrease) in contract liabilities and current deferred income decreased by 207.7% year-over-year, from $582K to -$627K.